Form D · Pharmaceuticals
GLOBEIMMUNE INC
Louisville, CO · CIK 0001245104
Offering snapshot reported Mar 23, 2017 · SEC filing
- Reported sold
- $2.1M Offering amount: $2.1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 20, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 23, 2017 | Initial | $2,100,000 | No comparison | 1 | SEC filing |
| Jun 10, 2014 | Amendment | $7,500,000 | $0vs Feb 13, 2014 | 110 | SEC filing |
| Mar 12, 2014 | Initial | $391,730 | No comparison | 1 | SEC filing |
| Feb 13, 2014 | Initial | $7,500,000 | No comparison | 92 | SEC filing |
| Feb 3, 2010 | Amendment | $17,999,124 | $491,308vs Jan 27, 2010 | 27 | SEC filing |
| Jan 27, 2010 | Initial | $17,507,816 | No comparison | 26 | SEC filing |
| May 20, 2009 | Initial | $13,000,000 | No comparison | Not reported | SEC filing |
| Mar 17, 2009 | Initial | $2,564,710 | No comparison | Not reported | SEC filing |
| Jul 23, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 15, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 7, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-283236
Consideration consisted of $100,000 in cash and purchaser securities in the aggregate value of $2.0 million.
Source: Form D, filed Mar 23, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Apelian | Executive |
| Jerel Banks | Director |
| Darren Carroll | Director |
| Ralph E Christoffersen | Director |
| Kirk A Christoffersen | Executive |
| C Jeffrey Dekker | Executive |
| C. Jeffrey Dekker | Executive |
| John Frenz | Executive |
| J. William Freytag | Director |
| J William Freytag | Director |
| Ehud Geller | Director |
| Charles Kim | Director |
| Augustine J Lawlor | Director |
| Paul A Mieyal | Director |
| Dan J Mitchell | Director |
| Timothy C. Rodell | Director |
| Jeff Rona | Executive |
| Pennina Safer | Director |
| S Edward Torres | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1450 Infinite Drive
Louisville, CO, 80027
Louisville, CO, 80027